IDH1 and acute myeloid leukemia: Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) occur in approximately 15–20% of AML cases and contribute to leukemogenesis through the production of the oncometabolite 2-hydroxyglutarate, which blocks normal hematopoietic differentiation [7,51].